Laboratory of Analytical Microbiology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Scand J Immunol. 2010 Nov;72(5):425-33. doi: 10.1111/j.1365-3083.2010.02456.x.
The subunit vaccine SV1 (20 μg F1+10 μg rV270) has been identified as the optimal formulation in mice, which provided a good protection against plague in mice, guinea pigs and rabbits. To compare SV1 and SV2 (200 μg F1+100 μg rV270) with live attenuated vaccine EV76, antibody responses, protective efficacy, cytokines (IFN-γ, TNF-α, IL-2, IL-4, IL-10 and IL-12) production, CD4/CD8 ratio and CD69(+) T-cell activation marker were determined in sera of the immunized Chinese-origin rhesus macaques, Macaca mulatta. The immunized animals with SV1 or SV2 developed higher anti-rV270 IgG titre, while those immunized with EV76 elicited a negligible IgG to V antigen, indicating that subunit vaccine (SV) had an advantage over EV76 in terms of the indispensable role of anti-V antibody against Yersinia pestis. There was no significant antibody titre difference between SV1 and SV2, suggesting that the immune response may have been saturated at the dose level of SV1. There were no statistical changes for CD4/CD8 ratios, IL-4 and CD69 levels between the three-vaccine immunized groups. However, a significant higher level of IL-12 was observed in the EV76 immunized animals, indicating that EV76 had an advantage over SV in respect of cellular immunity. Complete protection was observed for the immunized animals with SV and EV76, revealing that SV has a similar protective efficacy with EV76 against 6×10⁶ CFU of Y. pestis challenge by subcutaneous route in Chinese-origin rhesus macaques.
亚单位疫苗 SV1(20 μg F1+10 μg rV270)已被确定为在小鼠中最佳的配方,它为小鼠、豚鼠和兔子提供了良好的鼠疫保护。为了比较 SV1 和 SV2(200 μg F1+100 μg rV270)与减毒活疫苗 EV76,在免疫的中国恒河猴血清中测定了抗体反应、保护效力、细胞因子(IFN-γ、TNF-α、IL-2、IL-4、IL-10 和 IL-12)产生、CD4/CD8 比值和 CD69(+)T 细胞激活标志物。用 SV1 或 SV2 免疫的动物产生了更高的抗 rV270 IgG 滴度,而用 EV76 免疫的动物则产生了可忽略不计的抗 V 抗原 IgG,表明亚单位疫苗(SV)在抗鼠疫耶尔森氏菌 V 抗原抗体的不可或缺作用方面优于 EV76。SV1 和 SV2 之间的抗体滴度没有显著差异,表明在 SV1 的剂量水平上,免疫反应可能已经饱和。三种疫苗免疫组之间的 CD4/CD8 比值、IL-4 和 CD69 水平没有统计学变化。然而,在 EV76 免疫的动物中观察到 IL-12 水平显著升高,表明 EV76 在细胞免疫方面优于 SV。SV 和 EV76 免疫的动物完全得到保护,表明 SV 对中国恒河猴 6×106 CFU 鼠疫耶尔森氏菌的皮下攻击具有与 EV76 相似的保护效力。